Participants 40 153 6
postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer
Participants 318 386 4
postmenopausal women with highly endocrine responsive breast cancer.
Participants 464 575 5
postmenopausal women with node-positive, estrogen receptor (ER)-positive or ER-negative, operable breast cancer
Participants 729 854 3
893 patients with endocrine-responsive disease, and according to prospectively defined categories of ER, age and nodal status
Participants 1281 1341 3
postmenopausal women with endocrine-responsive breast cancer
